Richard Johnson

President and Chief Executive Officer, Parenteral Drug Association

“Day-to-day, I never forget that the ultimate users of pharmaceutical products are people, including our families, friends and ourselves. Many of the biggest impacts on modern life have come through better prevention and treatment of diseases. Life expectancy and quality of life have dramatically changed in my lifetime, and any contribution that I can make is an intrinsic good! But I would like to see more focus on improving the manufacturing of pharma products. The predominant business model is to focus on new therapies, but without a corresponding focus on improving the manufacturing of these products, many patients will not receive the quality of pharma products they need. Exciting new therapies are coming into the market: cell and gene therapies, and integrated drug, device, diagnostic products. We must also continue to focus on improving the manufacture of existing therapies, that serve the vast majority of patients worldwide.”

Part of the Power List 2019

Breakthroughs at the bench, novel technologies and groundbreaking policies and regulation have helped the pharma industry grow from strength to strength. After months of collating reader nominations and judging overseen by a panel of industry experts, we proudly present The Medicine Maker 2019 Power List, featuring 100 of the industry’s pioneers across four categories: Industry Influencers, Business Captains, Masters of the Bench, and Champions of Change.

Go to The Power List 2019